<bill session="111" type="s" number="613" updated="2013-07-20T00:28:49-04:00">
  <state datetime="2009-03-17">REFERRED</state>
  <status>
    <introduced datetime="2009-03-17"/>
  </status>
  <introduced datetime="2009-03-17"/>
  <titles>
    <title as="introduced" type="official">A bill to prohibit the use of Federal funds to approve certain biologics license applications by the Food and Drug Administration.</title>
  </titles>
  <sponsor id="300013"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2009-03-17">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government studies and investigations"/>
    <term name="Hazardous wastes and toxic substances"/>
    <term name="Iran"/>
    <term name="Licensing and registrations"/>
    <term name="Middle East"/>
    <term name="Sanctions"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <summary>3/17/2009--Introduced.
Prohibits the use of funds by the Food and Drug Administration (FDA) to process a biologics license application for any biologic product that is, bears, or contains an agent or toxin listed in federal regulations as dangerous to life, property, or the environment and that has been marketed, sold, or distributed to the Islamic Republic of Iran by an entity under investigation for potential violations of the Iran Sanctions Act of 1996.</summary>
</bill>
